ALEXIS HOUSER: Open Payments
NPI 1407488778 · MELBOURNE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$620 in 18 payments from 9 companies in 2025. Trend: 2023 $532 · 2024 $483 · 2025 $620
Food & beverage: $620
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 4 | $170 |
| AstraZeneca Pharmaceuticals LP | 1 | $125 |
| Phathom Pharmaceuticals, Inc. | 1 | $94 |
| Exact Sciences Corporation | 3 | $73 |
| ABBVIE INC. | 3 | $58 |
| Novo Nordisk Inc | 3 | $48 |
| Optinose US, Inc. | 1 | $19 |
| Astellas Pharma US Inc | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: MOUNJARO, BREZTRI, VOQUEZNA, Cologuard Collection Kit, UBRELVY, Ozempic, The Cologuard Plus Collection Kit, Xhance.
Industry payments across FL — which companies pay providers there.
